𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Study of the long term effect of high gamma doses in the crystalline phase of P(VdF-TrFE) copolymers

✍ Scribed by A.S. Medeiros; L.O. Faria

Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
404 KB
Volume
268
Category
Article
ISSN
0168-583X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of crystallization temperature on
Effect of crystallization temperature on the phase transitions of P(VDF/TrFE) copolymers
✍ Rinaldo Gregorio Jr.; Marcelo Marino Botta πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 2 views

A systematic study was carried out on the effect of the crystallization temperature (T cr ), on the phase transitions presented by P(VDF/TrFE) copolymers cast from dimethylformamide (DMF) solution with molar ratios 60/40, 70/30, and 80/20. The results obtained by differential scanning calorimetry (D

Dose-dependent long-term effects of Tat
Dose-dependent long-term effects of Tat in the rat hippocampal formation: A design-based stereological study
✍ Sylvia Fitting; Rosemarie M. Booze; Ulla Hasselrot; Charles F. Mactutus πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 816 KB

## Abstract The human immunodeficiency virus type 1 (HIV‐1) protein transactivator of transcription (Tat) is believed to play a critical role in mediating central nervous system (CNS) pathology in pediatric HIV‐1 infection. Long‐term neurotoxicity was investigated in a design‐based stereology study

Long-term follow-up of a phase I study o
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
✍ Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris